Epigenetic Targets in Schizophrenia Development and Therapy.

adolescence animal models antipsychotics environment genetics human studies neurodevelopment pharmacotherapy psychosis treatment-resistance

Journal

Brain sciences
ISSN: 2076-3425
Titre abrégé: Brain Sci
Pays: Switzerland
ID NLM: 101598646

Informations de publication

Date de publication:
01 Mar 2023
Historique:
received: 27 01 2023
revised: 24 02 2023
accepted: 26 02 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Schizophrenia is regarded as a neurodevelopmental disorder with its course progressing throughout life. However, the aetiology and development of schizophrenia are still under investigation. Several data suggest that the dysfunction of epigenetic mechanisms is known to be involved in the pathomechanism of this mental disorder. The present article revised the epigenetic background of schizophrenia based on the data available in online databases (PubMed, Scopus). This paper focused on the role of epigenetic regulation, such as DNA methylation, histone modifications, and interference of non-coding RNAs, in schizophrenia development. The article also reviewed the available data related to epigenetic regulation that may modify the severity of the disease as a possible target for schizophrenia pharmacotherapy. Moreover, the effects of antipsychotics on epigenetic malfunction in schizophrenia are discussed based on preclinical and clinical results. The obtainable data suggest alterations of epigenetic regulation in schizophrenia. Moreover, they also showed the important role of epigenetic modifications in antipsychotic action. There is a need for more data to establish the role of epigenetic mechanisms in schizophrenia therapy. It would be of special interest to find and develop new targets for schizophrenia therapy because patients with schizophrenia could show little or no response to current pharmacotherapy and have treatment-resistant schizophrenia.

Identifiants

pubmed: 36979236
pii: brainsci13030426
doi: 10.3390/brainsci13030426
pmc: PMC10046502
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : National Science Center
ID : 2018/31/B/NZ4/01465.

Références

Int J Neuropsychopharmacol. 2014 May;17(5):723-37
pubmed: 24345457
Front Genet. 2021 Jun 28;12:686666
pubmed: 34262598
JAMA Psychiatry. 2020 Feb 1;77(2):201-210
pubmed: 31664453
Curr Opin Psychiatry. 2017 May;30(3):191-196
pubmed: 28230630
Front Psychiatry. 2022 Aug 30;13:994425
pubmed: 36111312
Neurobiol Dis. 2018 Nov;119:149-158
pubmed: 30099093
Cell Rep. 2020 Sep 15;32(11):108126
pubmed: 32937141
J Neurochem. 2017 Nov;143(3):320-333
pubmed: 28628228
Psychiatr Clin North Am. 2007 Sep;30(3):323-38
pubmed: 17720026
Prog Neurobiol. 2021 May;200:101968
pubmed: 33279625
Neuropsychiatr Dis Treat. 2020 Feb 21;16:519-534
pubmed: 32110026
J Psychiatr Res. 2014 Jul;54:134-40
pubmed: 24694668
Front Mol Neurosci. 2019 May 09;12:97
pubmed: 31143100
Cells. 2022 Aug 21;11(16):
pubmed: 36010683
Medicine (Baltimore). 2016 Jan;95(4):e2475
pubmed: 26825886
Neuropsychopharmacology. 2019 Jan;44(2):443-454
pubmed: 30038413
Front Pharmacol. 2019 Dec 06;10:1393
pubmed: 31866860
Clin Epigenetics. 2021 Aug 27;13(1):166
pubmed: 34452630
Nat Genet. 2017 Jan;49(1):27-35
pubmed: 27869829
Mol Psychiatry. 2022 Jul;27(7):2950-2967
pubmed: 35444257
Transl Psychiatry. 2021 Dec 20;11(1):643
pubmed: 34930904
Sci Adv. 2022 Mar 4;8(9):eabm1077
pubmed: 35245111
Biosci Rep. 2021 Jun 25;41(6):
pubmed: 33997894
J Neurodev Disord. 2020 Dec 16;12(1):37
pubmed: 33327934
Neurobiol Dis. 2019 Nov;131:104257
pubmed: 30170114
Metab Brain Dis. 2019 Feb;34(1):341-352
pubmed: 30519836
J Psychiatr Res. 2021 May;137:89-95
pubmed: 33662656
Schizophr Res. 2014 Dec;160(1-3):97-103
pubmed: 25445625
Cold Spring Harb Perspect Biol. 2014 Apr 01;6(4):a018713
pubmed: 24691964
Biol Psychiatry. 2022 Jan 15;91(2):170-172
pubmed: 34916029
Int J Mol Sci. 2017 Mar 14;18(3):
pubmed: 28335437
Proc Natl Acad Sci U S A. 2008 Sep 9;105(36):13614-9
pubmed: 18757738
Pharmacol Rep. 2013;65(5):1112-23
pubmed: 24399707
Transl Psychiatry. 2020 Apr 22;10(1):115
pubmed: 32321908
Schizophr Res. 2020 Oct;224:58-66
pubmed: 33289658
Psychiatry Res. 2019 Aug;278:146-150
pubmed: 31200193
Transl Psychiatry. 2011 Dec 20;1:e64
pubmed: 22832356
Front Psychiatry. 2021 Mar 05;12:536257
pubmed: 33746786
Schizophr Res. 2018 May;195:32-50
pubmed: 28947341
Eur Arch Psychiatry Clin Neurosci. 2018 Oct;268(7):625-639
pubmed: 29368205
Nat Rev Mol Cell Biol. 2019 Oct;20(10):590-607
pubmed: 31399642
PLoS One. 2019 Jun 11;14(6):e0216463
pubmed: 31185023
J Psychiatr Res. 2018 Sep;104:88-95
pubmed: 30005373
Sci Adv. 2022 Jan 21;8(3):eabi6696
pubmed: 35044827
Psychiatry Res. 2016 Oct 30;244:324-32
pubmed: 27512922
Eur Neuropsychopharmacol. 2014 Feb;24(2):271-89
pubmed: 23932495
Neuron. 2016 Mar 2;89(5):940-7
pubmed: 26938441
Mol Psychiatry. 2014 Jul;19(7):848-52
pubmed: 23917947
Neuropharmacology. 2019 Oct;157:107675
pubmed: 31233824
Psychopharmacology (Berl). 2013 May;227(1):67-78
pubmed: 23318695
J Med Biochem. 2019 May 11;38(3):299-305
pubmed: 31156340
Genome Biol. 2007;8(2):R27
pubmed: 17326821
Curr Psychiatry Rep. 2008 Apr;10(2):148-57
pubmed: 18474208
Int J Mol Sci. 2020 Apr 03;21(7):
pubmed: 32260096
Front Cell Neurosci. 2022 Nov 28;16:1037105
pubmed: 36519081
Int J Neuropsychopharmacol. 2012 Nov;15(10):1489-501
pubmed: 22093154
Psychiatry Res. 1998 Nov 16;81(2):101-10
pubmed: 9858027
Front Psychiatry. 2021 Dec 22;12:789179
pubmed: 35002807
Neurosci Biobehav Rev. 2020 Jun;113:546-567
pubmed: 32320814
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Front Genet. 2019 Jul 10;10:641
pubmed: 31354789
Schizophr Res. 2022 Aug;246:175-186
pubmed: 35785580
Nat Neurosci. 2016 Apr;19(4):571-7
pubmed: 26974950
Indian J Psychiatry. 2017 Oct-Dec;59(4):505-509
pubmed: 29497198
Psychiatry Res. 2022 Nov;317:114789
pubmed: 36075150
BMJ Case Rep. 2021 Apr 13;14(4):
pubmed: 33849886
Psychiatr Clin North Am. 2003 Mar;26(1):41-63
pubmed: 12683259
Psychiatry Res. 2018 Jan;259:501-505
pubmed: 29154172
Schizophr Res. 2013 Sep;149(1-3):15-20
pubmed: 23815974
Prog Mol Biol Transl Sci. 2014;128:89-101
pubmed: 25410542
Neuron. 2014 May 21;82(4):773-80
pubmed: 24853937
Curr Issues Mol Biol. 2021 Jul 08;43(2):618-636
pubmed: 34287249
Am J Med Genet B Neuropsychiatr Genet. 2015 Dec;168(8):687-96
pubmed: 26285059
J Psychiatr Res. 2018 May;100:84-87
pubmed: 29499474
Schizophr Res. 2011 Feb;125(2-3):161-8
pubmed: 21075600
Mol Psychiatry. 2019 Jun;24(6):869-887
pubmed: 30116031
CNS Spectr. 2018 Jun;23(3):187-191
pubmed: 29954475
NPJ Schizophr. 2021 Apr 26;7(1):22
pubmed: 33903594
Neuropsychiatr Dis Treat. 2020 Dec 01;16:2891-2897
pubmed: 33293814
Signal Transduct Target Ther. 2022 Jul 6;7(1):217
pubmed: 35794091
Nat Commun. 2022 Jul 22;13(1):4249
pubmed: 35869095
J Mol Psychiatry. 2013 Nov 04;1(1):19
pubmed: 25408910
Neuron. 2014 Dec 3;84(5):997-1008
pubmed: 25467983
JAMA Psychiatry. 2016 Jul 1;73(7):665-74
pubmed: 27304221
Front Psychiatry. 2021 Sep 20;12:734606
pubmed: 34616320
Psychol Med. 2019 Sep;49(12):1971-1979
pubmed: 31284882
JAMA Psychiatry. 2015 Apr;72(4):316-24
pubmed: 25651194
J Neurosci. 2007 Oct 17;27(42):11254-62
pubmed: 17942719
Clin Epigenetics. 2019 May 16;11(1):81
pubmed: 31097014
Schizophr Bull. 2017 Jan;43(1):64-74
pubmed: 28053131
Cells. 2020 Aug 05;9(8):
pubmed: 32764320
Psychiatry Res. 2021 Nov;305:114218
pubmed: 34638051
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Dec 20;95:109679
pubmed: 31254573
Schizophr Bull. 2014 Mar;40(2):399-409
pubmed: 23378013
Cell. 2013 Aug 1;154(3):490-503
pubmed: 23911317
Pharmacol Ther. 2023 Jan;241:108279
pubmed: 36103902
Front Neurosci. 2021 Nov 03;15:776809
pubmed: 34803599
Am J Med Genet B Neuropsychiatr Genet. 2016 Dec;171(8):1170-1179
pubmed: 27762073
Psychiatry Res. 2016 Nov 30;245:200-206
pubmed: 27552670
Chem Biol Interact. 2022 Sep 1;364:110042
pubmed: 35853541
Clin Psychopharmacol Neurosci. 2022 Nov 30;20(4):685-693
pubmed: 36263643
Int J Neuropsychopharmacol. 2014 Apr;17(4):645-9
pubmed: 24331356
Neuropharmacology. 2011 Jun;60(7-8):1007-16
pubmed: 21074545
Neuropharmacology. 2019 Mar 1;146:212-221
pubmed: 30496751
Front Psychiatry. 2021 Mar 18;12:653821
pubmed: 33815179
J Neurochem. 2005 Apr;93(2):483-92
pubmed: 15816871
NPJ Schizophr. 2020 Jan 7;6(1):1
pubmed: 31911624
Nat Neurosci. 2016 Nov;19(11):1433-1441
pubmed: 27694994
Psychopharmacology (Berl). 2020 Jan;237(1):231-248
pubmed: 31654083
Mol Psychiatry. 2020 Apr;25(4):873-882
pubmed: 29934548
Psychiatr Genet. 2020 Feb;30(1):1-9
pubmed: 31764709
Front Behav Neurosci. 2021 Jun 11;15:689193
pubmed: 34177484
Psychiatr Clin North Am. 2020 Jun;43(2):263-274
pubmed: 32439021
Mol Cell Biol. 2008 Nov;28(21):6720-9
pubmed: 18765639
J Nerv Ment Dis. 2015 May;203(5):328-35
pubmed: 25919383
Eur Neuropsychopharmacol. 2018 Jan;28(1):97-108
pubmed: 29174863
Nat Commun. 2022 Apr 22;13(1):2195
pubmed: 35459277
Genes (Basel). 2017 May 23;8(6):
pubmed: 28545252
Front Neurosci. 2019 Mar 21;13:274
pubmed: 30983960
J Med Chem. 2014 Jan 23;57(2):421-34
pubmed: 24328113
Br J Psychiatry. 2022 Mar;220(3):115-120
pubmed: 35049446
Neuroscience. 2018 Sep 15;388:102-117
pubmed: 30025863
Brain Behav Immun. 2020 Aug;88:547-558
pubmed: 32330592
Mol Pharmacol. 2019 Jan;95(1):62-69
pubmed: 30397000
Int J Mol Sci. 2021 Aug 13;22(16):
pubmed: 34445411
Trends Mol Med. 2011 Jul;17(7):372-9
pubmed: 21429800
Brain Behav Immun. 2018 Jul;71:28-36
pubmed: 29730395
Schizophrenia (Heidelb). 2022 Dec 8;8(1):110
pubmed: 36481661
Nat Rev Neurosci. 2017 Dec;18(12):727-740
pubmed: 29070826
Biochem Soc Trans. 2004 Dec;32(Pt 6):910-2
pubmed: 15506921
Mol Pharmacol. 2007 Mar;71(3):644-53
pubmed: 17065238
Genes (Basel). 2022 Mar 02;13(3):
pubmed: 35328011
NPJ Schizophr. 2016 Mar 09;2:16003
pubmed: 27336054
Nat Neurosci. 2012 Sep;15(9):1245-54
pubmed: 22864611
Schizophr Bull. 2018 Aug 20;44(5):973-982
pubmed: 29648618
Mol Psychiatry. 2021 Nov;26(11):6926-6936
pubmed: 34588622
Brain Behav Immun. 2013 May;30:168-75
pubmed: 23402795
Nat Rev Mol Cell Biol. 2021 Feb;22(2):96-118
pubmed: 33353982
World Psychiatry. 2009 Feb;8(1):15-22
pubmed: 19293950
Cells. 2021 Oct 06;10(10):
pubmed: 34685659
Nat Med. 2018 Jun;24(6):792-801
pubmed: 29808008
Psychopharmacology (Berl). 2005 Jul;180(2):191-205
pubmed: 15864560
Hum Mol Genet. 2020 Jan 1;29(1):159-167
pubmed: 31691811
Pharmacol Rep. 2015 Dec;67(6):1124-9
pubmed: 26481530
Transl Psychiatry. 2014 Sep 02;4:e434
pubmed: 25180573
World J Biol Psychiatry. 2019 Sep;20(7):545-554
pubmed: 29938562

Auteurs

Agnieszka Wawrzczak-Bargieła (A)

Department of Pharmacology, Laboratory of Pharmacology and Brain Biostructure, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.

Wiktor Bilecki (W)

Department of Pharmacology, Laboratory of Pharmacology and Brain Biostructure, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.

Marzena Maćkowiak (M)

Department of Pharmacology, Laboratory of Pharmacology and Brain Biostructure, Maj Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, 31-343 Kraków, Poland.

Classifications MeSH